CuroGens Europa IVS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  27.6% 22.9% 15.2% 28.2% 19.9%  
Credit score (0-100)  4 5 14 3 6  
Credit rating  B B BB B B  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12

Net sales  2,403 2,621 2,125 2,610 1,824  
Gross profit  53.8 257 4.8 96.8 122  
EBITDA  53.8 257 4.8 -54.7 17.6  
EBIT  53.8 257 4.8 -54.7 17.6  
Pre-tax profit (PTP)  58.4 264.0 0.7 -57.5 15.6  
Net earnings  45.6 205.9 0.5 -57.5 15.6  
Pre-tax profit without non-rec. items  58.4 264 0.7 -57.5 15.6  

 
See the entire income statement

Balance sheet (kDKK) 
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  45.7 206 0.6 30.2 44.4  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  241 358 318 59.6 53.3  

Net Debt  -67.2 -332 -40.9 -59.6 -53.3  
 
See the entire balance sheet

Volume 
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12

Net sales  2,403 2,621 2,125 2,610 1,824  
Net sales growth  0.0% 9.1% -18.9% 22.8% -30.1%  
Gross profit  53.8 257 4.8 96.8 122  
Gross profit growth  0.0% 378.1% -98.1% 1,910.9% 26.3%  
Employees  0 0 0 0 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 -151.5 -104.6  
Balance sheet total (assets)  241 358 318 60 53  
Balance sheet change%  0.0% 48.9% -11.2% -81.3% -10.7%  
Added value  53.8 257.3 4.8 96.8 122.2  
Added value %  2.2% 9.8% 0.2% 3.7% 6.7%  
Investments  0 0 0 0 0  

Net sales trend  0.0 1.0 -1.0 1.0 -1.0  
EBIT trend  1.0 2.0 3.0 -1.0 1.0  

Profitability 
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
EBITDA %  2.2% 9.8% 0.2% -2.1% 1.0%  
EBIT %  2.2% 9.8% 0.2% -2.1% 1.0%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% -56.6% 14.4%  
Net Earnings %  1.9% 7.9% 0.0% -2.2% 0.9%  
Profit before depreciation and extraordinary items %  1.9% 7.9% 0.0% -2.2% 0.9%  
Pre tax profit less extraordinaries %  2.4% 10.1% 0.0% -2.2% 0.9%  
ROA %  25.9% 88.9% 1.5% -28.9% 31.3%  
ROI %  136.3% 211.6% 4.8% -353.6% 47.4%  
ROE %  99.8% 163.6% 0.5% -373.0% 41.9%  

Solidity 
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Equity ratio %  19.0% 57.5% 0.2% 50.6% 83.4%  
Relative indebtedness %  8.1% 5.8% 14.9% 1.1% 0.5%  
Relative net indebtedness %  5.3% -6.9% 13.0% -1.2% -2.4%  
Net int. bear. debt to EBITDA, %  -124.9% -129.1% -849.6% 108.9% -302.6%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Quick Ratio  1.3 3.8 1.0 2.0 6.0  
Current Ratio  1.3 3.8 1.0 2.0 6.0  
Cash and cash equivalent  67.2 332.2 40.9 59.6 53.3  

Capital use efficiency 
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Trade debtors turnover (days)  26.3 3.7 11.2 0.0 0.0  
Trade creditors turnover (days)  14.8 14.6 54.6 0.0 0.0  
Current assets / Net sales %  10.0% 13.7% 15.0% 2.3% 2.9%  
Net working capital  58.5 264.1 0.8 30.2 44.4  
Net working capital %  2.4% 10.1% 0.0% 1.2% 2.4%  

Employee efficiency 
2016
2016/12
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Net sales / employee  0 0 0 0 1,824  
Added value / employee  0 0 0 0 122  
Employee expenses / employee  0 0 0 0 -105  
EBITDA / employee  0 0 0 0 18  
EBIT / employee  0 0 0 0 18  
Net earnings / employee  0 0 0 0 16